Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000953336
Ethics application status
Approved
Date submitted
26/06/2017
Date registered
4/07/2017
Date last updated
8/06/2018
Type of registration
Prospectively registered

Titles & IDs
Public title
Modelling and measuring anaesthetic gas uptake by the lung
Scientific title
Measurement of the partial pressure cascade for anaesthetic agents during inhalational anaesthesia for cardiac surgery
Secondary ID [1] 292291 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Lung uptake of anaesthetic gases 303811 0
Inhalational anaesthesia 303812 0
Condition category
Condition code
Anaesthesiology 303178 303178 0 0
Anaesthetics

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
The partial pressure cascade for sevoflurane and desflurane will be measured in patients undergoing inhalational general anaesthesia for cardiac surgery. Measurements of inspired, end-tidal, arterial and mixed venous partial pressure of anaesthetic agent and oxygen and CO2 will be made at one time point during the pre-cardiopulmonary bypass phase. Calculation of pulmonary deadspace and shunt will be done as indices of ventilation perfusion scatter in all patients. In a further group of 10 patients ventilation perfusion scatter will be formally quantified uisng the mIGET.
Intervention code [1] 298465 0
Not applicable
Comparator / control treatment
Patients act as their own controls
Control group
Uncontrolled

Outcomes
Primary outcome [1] 302566 0
The Alveolar deadspace fraction for the anaesthetic agents will be measured from the alveolar-arterial gradient via the Bohr-Enghoff equation, and compared to that calculated in the traditional way using simultaneous PCO2 measurements.
Timepoint [1] 302566 0
60 minutes post induction of anaesthesia or the nearest point where stability of cardiovascular and measured variables is maintained for at least 5 minutes.
Secondary outcome [1] 336377 0
Relationship of A-a differences and pulmonary deadspace to V/Q scatter measured using the MIGET
Timepoint [1] 336377 0
60 minutes post induction of anaesthesia or the nearest point where stability of cardiovascular and measured variables is maintained for at least 5 minutes.

Eligibility
Key inclusion criteria
Patients undergoing coronary artery bypass surgery
Minimum age
18 Years
Maximum age
85 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Patients unable to provide informed consent
Women who are pregnant
Patients with cognitive impairment
Patients with moderately or severely impaired respiratory function on history and examination (FEV1 or FVC < 50% predicted)
Patients with morbid obesity (Body mass index (BMI) > 40 kg/m2)

Study design
Purpose
Natural history
Duration
Cross-sectional
Selection
Defined population
Timing
Both
Statistical methods / analysis
Mean alveolar deadspace for CO2 will be compared with that for volatile agent.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/01/2019
Actual
Date of last participant enrolment
Anticipated
31/12/2020
Actual
Date of last data collection
Anticipated
31/12/2020
Actual
Sample size
Target
30
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 8453 0
Austin Health - Austin Hospital - Heidelberg
Recruitment postcode(s) [1] 16528 0
3084 - Heidelberg

Funding & Sponsors
Funding source category [1] 296835 0
Charities/Societies/Foundations
Name [1] 296835 0
ANZCA Research Foundataion
Country [1] 296835 0
Australia
Primary sponsor type
Hospital
Name
Austin Health
Address
Studley Rd
Heidelberg
VIC 3084
Country
Australia
Secondary sponsor category [1] 295829 0
None
Name [1] 295829 0
Address [1] 295829 0
Country [1] 295829 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 298067 0
Austin Health
Ethics committee address [1] 298067 0
Ethics committee country [1] 298067 0
Australia
Date submitted for ethics approval [1] 298067 0
28/07/2016
Approval date [1] 298067 0
21/10/2016
Ethics approval number [1] 298067 0
DT 16/419

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 75882 0
A/Prof Philip Peyton
Address 75882 0
Dept of Anaesthesia
Austin Health
Studley Rd
Heidelberg 3084
Country 75882 0
Australia
Phone 75882 0
+61 3 94965000
Fax 75882 0
Email 75882 0
[email protected]
Contact person for public queries
Name 75883 0
Philip Peyton
Address 75883 0
Dept of Anaesthesia
Austin Health
Studley Rd
Heidelberg 3084
Country 75883 0
Australia
Phone 75883 0
+61 3 94965000
Fax 75883 0
Email 75883 0
[email protected]
Contact person for scientific queries
Name 75884 0
Philip Peyton
Address 75884 0
Dept of Anaesthesia
Austin Health
Studley Rd
Heidelberg 3084
Country 75884 0
Australia
Phone 75884 0
+61 3 94965000
Fax 75884 0
Email 75884 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.